PhenomeX Inc. Common Stock
CELL
CELL was delisted on the 29th of September, 2023.
113 hedge funds and large institutions have $138M invested in PhenomeX Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 37 reducing their positions, and 24 closing their positions.
46% more call options, than puts
Call options by funds: $101K | Put options by funds: $69K
8% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 37
8% less funds holding
Funds holding: 123 → 113 (-10)
42% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 24
43% less capital invested
Capital invested by funds: $244M → $138M (-$106M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NIMC
Nierenberg Investment Management Company
Camas,
Washington
|
+$5.43M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$3.31M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.77M |
| 4 |
JP Morgan Chase
New York
|
+$1.04M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$12.6M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$2.14M |
| 3 |
Morgan Stanley
New York
|
-$1.41M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.41M |
| 5 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$1.24M |
CELL Hedge Fund Activity: Q3 2022 in Review
113 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in PhenomeX Inc. Common Stock (CELL) for Q3 2022, worth a combined $138M — down 43% from $244M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of CELL and 14 opened new positions — a net loss of 10 holders — while 37 trimmed existing stakes and 34 added.
The largest buyer was Nierenberg Investment Management Company, adding an estimated $5.43M. The largest seller was ARK Investment Management, cutting an estimated $12.6M.
- 113 institutional investors held PhenomeX Inc. Common Stock (CELL) as of Q3 2022, down from 123 in Q2 2022.
- Funds reported $138M of PhenomeX Inc. Common Stock stock for Q3 2022, down 43% quarter-over-quarter.
- 14 funds opened new PhenomeX Inc. Common Stock positions in Q3 2022 and 24 closed out, a net change of -10 holders.
- The largest PhenomeX Inc. Common Stock buyer in Q3 2022 was Nierenberg Investment Management Company, an estimated $5.43M added.
- The largest PhenomeX Inc. Common Stock seller in Q3 2022 was ARK Investment Management, an estimated $12.6M sold.
Based on aggregated 13F filings for Q3 2022.